Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2003 1
2004 4
2005 4
2006 1
2007 6
2008 1
2009 1
2010 2
2011 3
2012 3
2013 6
2014 3
2016 2
2017 3
2018 2
2019 5
2020 9
2021 5
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
The impact of elexacaftor/tezacaftor/ivacaftor therapy on the pulmonary management of adults with cystic fibrosis: An expert-based Delphi consensus.
Gramegna A, Aliberti S, Calderazzo MA, Casciaro R, Ceruti C, Cimino G, Fabrizzi B, Lucanto C, Messore B, Pisi G, Taccetti G, Tarsia P, Blasi F, Cipolli M. Gramegna A, et al. Among authors: tarsia p. Respir Med. 2023 Dec;220:107455. doi: 10.1016/j.rmed.2023.107455. Epub 2023 Nov 3. Respir Med. 2023. PMID: 37926181 Free article.
Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric Observational Study in Times of Health Emergency.
Ughi N, Bernasconi DP, Del Gaudio F, Dicuonzo A, Maloberti A, Giannattasio C, Tarsia P, Travi G, Scaglione F, Colombo F, Bertuzzi M, Adinolfi A, Valsecchi MG, Rossetti C, Epis OM; Niguarda COVID Working Group. Ughi N, et al. Among authors: tarsia p. Clin Drug Investig. 2023 Oct;43(10):763-771. doi: 10.1007/s40261-023-01304-4. Epub 2023 Sep 22. Clin Drug Investig. 2023. PMID: 37740148
Trends in all-cause mortality of hospitalized patients due to SARS-CoV-2 infection from a monocentric cohort in Milan (Lombardy, Italy).
Ughi N, Bernasconi DP, Del Gaudio F, Dicuonzo A, Maloberti A, Giannattasio C, Tarsia P, Puoti M, Scaglione F, Beltrami L, Colombo F, Bertuzzi M, Bellone A, Adinolfi A, Valsecchi MG, Epis OM, Rossetti C; Niguarda COVID Working Group. Ughi N, et al. Among authors: tarsia p. Z Gesundh Wiss. 2022;30(8):1985-1993. doi: 10.1007/s10389-021-01675-y. Epub 2022 Jan 4. Z Gesundh Wiss. 2022. PMID: 35004128 Free PMC article.
Severe asthma: One disease and multiple definitions.
Bagnasco D, Paggiaro P, Latorre M, Folli C, Testino E, Bassi A, Milanese M, Heffler E, Manfredi A, Riccio AM, De Ferrari L, Blasi F, Canevari RF, Canonica GW, Passalacqua G; SANI (Severe Asthma Network Italy); Severe Asthma Network Italy. Bagnasco D, et al. World Allergy Organ J. 2021 Nov 19;14(11):100606. doi: 10.1016/j.waojou.2021.100606. eCollection 2021 Nov. World Allergy Organ J. 2021. PMID: 34871335 Free PMC article.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Sex differences in electrolyte imbalances caused by SARS-CoV-2: A cross-sectional study.
Pani A, Inglese E, Puoti M, Cento V, Alteri C, Romandini A, Di Ruscio F, Senatore M, Moreno M, Tarsia P, Colombo F, Epis OM, Panetta V, Vismara C, Bellone A, Scaglione F. Pani A, et al. Among authors: tarsia p. Int J Clin Pract. 2021 Dec;75(12):e14882. doi: 10.1111/ijcp.14882. Epub 2021 Oct 6. Int J Clin Pract. 2021. PMID: 34529866 Free PMC article.
Neurological manifestations in patients hospitalized with COVID-19: A retrospective analysis from a large cohort in Northern Italy.
Travi G, Rossotti R, Merli M, D'Amico F, Chiappetta S, Giussani G, Panariello A, Corradin M, Vecchi M, Raimondi A, Baiguera C, Nocita B, Epis OM, Tarsia P, Galbiati F, Colombo F, Fumagalli R, Scaglione F, Moreno M, Percudani ME, Agostoni EC, Puoti M; Niguarda COVID-19 Group. Travi G, et al. Among authors: tarsia p. Eur J Neurosci. 2021 Apr;53(8):2912-2922. doi: 10.1111/ejn.15159. Epub 2021 Mar 24. Eur J Neurosci. 2021. PMID: 33624380 Free PMC article.
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life.
Bagnasco D, Povero M, Pradelli L, Brussino L, Rolla G, Caminati M, Menzella F, Heffler E, Canonica GW, Paggiaro P, Senna G, Milanese M, Lombardi C, Bucca C, Manfredi A, Canevari RF, Passalacqua G; SANI Network (Severe Asthma Network Italy). Bagnasco D, et al. World Allergy Organ J. 2021 Jan 27;14(2):100509. doi: 10.1016/j.waojou.2021.100509. eCollection 2021 Feb. World Allergy Organ J. 2021. PMID: 33598095 Free PMC article.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
59 results